Stocks in News - 28 May 2021
Eicher Motors: The company reported sharply higher consolidated profit at Rs 526.14 crore in Q4FY21 against Rs 304.28 crore in Q4FY20, revenue jumped to Rs 2,940.33 crore from Rs 2,208.18 crore YoY.
Sun Pharma: The company reported higher profit at Rs 894.1 crore in Q4FY21 against Rs 399.8 crore in Q4FY20, revenue rose to Rs 8,523 crore from Rs 8,184.9 crore YoY.
Hester Biosciences: The company will invest Rs 40 crore for COVAXIN project and provide infra for manufacturing COVAXIN drug substance.
Metropolis Healthcare: The company reported sharply higher profit at Rs 61.3 crore in Q4FY21 against Rs 15.5 crore in Q4FY20, revenue jumped to Rs 291.7 crore from Rs 207 crore YoY.
Tata Consultancy Services: The company completed acquisition of GE's stake in Tata Consultancy Services Saudi Arabia on May 26.
NOCIL: The company reported higher consolidated profit at Rs 37.33 crore in Q4FY21 against Rs 21.87 crore in Q4FY20, revenue jumped to Rs 321.99 crore from Rs 212.66 crore YoY.
Jubilant Pharmova: India Ratings and Research has upgraded Long Term Issuer Rating to 'AA+' from 'AA' while resolving the Rating Watch Evolving (RWE) and has simultaneously withdrawn it. The Outlook is stable.
Eicher Motors: The company reported sharply higher consolidated profit at Rs 526.14 crore in Q4FY21 against Rs 304.28 crore in Q4FY20, revenue jumped to Rs 2,940.33 crore from Rs 2,208.18 crore YoY.
Sun Pharma: The company reported higher profit at Rs 894.1 crore in Q4FY21 against Rs 399.8 crore in Q4FY20, revenue rose to Rs 8,523 crore from Rs 8,184.9 crore YoY.
Hester Biosciences: The company will invest Rs 40 crore for COVAXIN project and provide infra for manufacturing COVAXIN drug substance.
Metropolis Healthcare: The company reported sharply higher profit at Rs 61.3 crore in Q4FY21 against Rs 15.5 crore in Q4FY20, revenue jumped to Rs 291.7 crore from Rs 207 crore YoY.
Tata Consultancy Services: The company completed acquisition of GE's stake in Tata Consultancy Services Saudi Arabia on May 26.
NOCIL: The company reported higher consolidated profit at Rs 37.33 crore in Q4FY21 against Rs 21.87 crore in Q4FY20, revenue jumped to Rs 321.99 crore from Rs 212.66 crore YoY.
Jubilant Pharmova: India Ratings and Research has upgraded Long Term Issuer Rating to 'AA+' from 'AA' while resolving the Rating Watch Evolving (RWE) and has simultaneously withdrawn it. The Outlook is stable.
Jublifoods breaking it's resistance
First time ever breaking keep an eye
First time ever breaking keep an eye
Results Today
29July 21
LICHSGFIN
TECHM
AJANTPHARM
AAVAS
TVSMOTOR
VAIBHAVGBL
UNIONBANK
COLPAL
POLYMED
PARAGMILK
PRIVISCL
VTL
PVR
GHCL
CONCOR
GESHIP
DEEPAKNTR
ADFFOODS
GENUSPOWER
DHANUKA
CCL
FRETAIL
FSL
EIHOTEL
KKCL
JKLAKSHMI
HITECH
LAURUSLABS
JSLHISAR
OBEROIRLTY
PRSMJOHNSN
JYOTHYLAB
RAYMOND
MOTILALOFS
MRPL
SOLARINDS
WELCORP
WELENT
SHOPERSTOP
SHREDIGCEM
29July 21
LICHSGFIN
TECHM
AJANTPHARM
AAVAS
TVSMOTOR
VAIBHAVGBL
UNIONBANK
COLPAL
POLYMED
PARAGMILK
PRIVISCL
VTL
PVR
GHCL
CONCOR
GESHIP
DEEPAKNTR
ADFFOODS
GENUSPOWER
DHANUKA
CCL
FRETAIL
FSL
EIHOTEL
KKCL
JKLAKSHMI
HITECH
LAURUSLABS
JSLHISAR
OBEROIRLTY
PRSMJOHNSN
JYOTHYLAB
RAYMOND
MOTILALOFS
MRPL
SOLARINDS
WELCORP
WELENT
SHOPERSTOP
SHREDIGCEM